Imaging 'the lost tribe': a review of adolescent cancer imaging. Part 2: imaging of complications of cancer treatment.
Adolescent cancers are treated with a host of chemotherapy agents, radiotherapy and stem cell transplantation. The complications of these treatments may contribute significantly to the morbidity and mortality in this age group, with imaging playing a role in identifying some of these complications. This second article reviews the imaging of acute and early complications relating to adolescent cancer treatment, many of which may also be seen in the treatment of paediatric patients. Late effects involving endocrine and reproductive systems or psychosocial considerations are not discussed in this paper, although these are clearly important issues in long-term survivors.
Zerizer
I
I
University College London Hospital NHS Trust, 235 Euston Road, London NW1, UK.
Humphries
P D
PD
D000293:Adolescent; D000970:Antineoplastic Agents / Q000009:adverse effects*; D001921:Brain / Q000187:drug effects; D018380:Hematopoietic Stem Cell Transplantation / Q000009:adverse effects; D006504:Hepatic Veno-Occlusive Disease / Q000175:diagnosis; D006801:Humans; D007239:Infections / Q000175:diagnosis; D008168:Lung / Q000187:drug effects; D008279:Magnetic Resonance Imaging; D009369:Neoplasms / Q000150:complications / Q000628:therapy*; D010020:Osteonecrosis / Q000175:diagnosis; D014057:Tomography, X-Ray Computed
D000970:Antineoplastic Agents